BiomX Inc. (PHGE) analyst actions
Rating and price-target actions on PHGE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PHGE overview →
1 measured PHGE analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis | Press release | -20.64% | -42.29% |
Keep exploring
More PHGE: earnings → · SEC filings → · PHGE overview →